AmbioPharm, Inc. expanding Aiken County operations

$18.8 million investment expected to create 100 new jobs
COLUMBIA, S.C. – AmbioPharm, Inc. (APi), a company that specializes in the manufacturing of peptides and the development of generic drugs, is expanding its existing Aiken County operations. The company is investing $18.8 million in the expansion and will create 100 new jobs over the next five years.

APi started their business in South Carolina in 2007, by establishing its company headquarters and downstream manufacturing operations in a 10,000-square-foot facility in the North Augusta Industrial Park. That same year, APi also opened its Shanghai, China operations, which focuses on synthesis, as well as the research and development of pharmaceutical products. In 2014, the company made major facility expansions by adding 10,000 square feet in North Augusta and 18,000 square feet in Shanghai. Between the two facilities, the company now employs more than 200 workers.

To expand its Aiken County operations, APi is planning to construct additional manufacturing suites and a new world headquarters building on the existing 32 acres that APi owns. In total, the new additions will add approximately 40,000 square feet to the company's existing facility at 1024 Dittman Court, North Augusta, South Carolina.

The expansion in North Augusta is anticipated to be completed by the third quarter of 2018. APi currently has numerous openings and hiring for the new positions is expected to begin immediately. Those interested in joining the APi team should contact the company via the email address: [email protected] For more information on the company, visit

The Coordinating Council for Economic Development has approved job development credits related to the project.


"Our expansion is the product of our hard-working, talented team of employees, the trust of our customers in the quality of our product and delivery system and the support we have received from the City of North Augusta, Aiken County and the State of South Carolina. The State truly knows how to work with rapidly growing enterprises." –AmbioPharm, Inc. Founder and Chief Executive Officer Dr. Chris Bai

"AmbioPharm's decision to build its headquarters in South Carolina is another example of how our workforce and business-friendly environment continue to attract companies to our state. This $18 million investment and the 100 new jobs it will create illustrates AmbioPharm's continued commitment to Aiken County and to South Carolina as a whole."  –Gov. Nikki Haley

"I have often said that whether its cars, planes or pharmaceuticals, South Carolina's manufacturing industry is thriving, and today's announcement by AmbioPharm is a testament to that. I offer my congratulations to APi on this significant expansion and look forward to supporting them as they continue to grow and prosper in our state." –Secretary of Commerce Bobby Hitt

"Aiken County is happy to congratulate AmbioPharm on its $18 million expansion that will create 100 new jobs in Aiken County.  It's gratifying that Dr. Bai and his team call Aiken County home. Aiken County Council is looking forward to continuing our partnership with them." –Aiken County Council Chairman Ronnie Young

"Successful economic development is more than just bringing in new companies. The continued growth of our existing industries plays a large role in the success of our city and county. Congratulations to AmbioPharm as they celebrate an $18 million expansion and 100 new jobs coming to our city." –City of North Augusta Mayor Lark Jones

"We are excited with Ambiopharm's continued commitment to Aiken County and the City of North Augusta. New capital investment and new jobs is always great news that we do not take for granted. Thank you and congratulations." –Aiken-Edgefield-Saluda Economic Development Partnership Chairman Gary Stooksbury


AmbioPharm, Inc. is expanding its existing Aiken County operations.
$18.8 million investment creating 100 new jobs over the next five years.
APi located in South Carolina in 2007, establishing its company headquarters and manufacturing operations in a 20,000-square-foot facility in the North Augusta Industrial Park.
APi is planning to construct additional purification process facilities and a new world headquarters building
Those interested in joining the APi team should contact Allison Lott at [email protected]
About AmbioPharm, Inc.
AmbioPharm, Inc. (APi) is a full-service peptide manufacturing company headquartered at our North Augusta, SC cGMP production site. Our second cGMP facility in Shanghai, China, performs process development & optimization, and manufactures building blocks, raw materials, and custom peptides at very large scale. Both our cGMP facilities are capable of handling any manufacturing scale required to produce bulk peptides to custom specifications using a wide range of skill sets in both solid and solution-phase chemistry. Our management team has over 100 years cumulative experience running pilot to commercial scale production. We also perform organic conjugations to small molecules, proteins, toxoids, antifungals, KLH, and PEG, visit

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.